CILIQUE - Clinical Outsourcing + Contract Management + CRO Vendor Selection & ManagementCILIQUE - Clinical Outsourcing + Contract Management + CRO Vendor Selection & Management
CILIQUE supports you with expertise in Clinical Outsourcing and Vendor Selection. We provide consulting and seminars for the pharmaceutical industry.
  • CILIQUE
    • Services
    • Fair Deal
  • CRO Database
    • Search for CROs for your next Project
    • Data Upload for CROs
  • Seminars & Workshops
  • Jobs
  • News
  • Team
  • Contact Us
Clinical Development Likelyhood of Approval tripple when using Biomarkers
24 Feb 2017

Clinical Development Likelyhood of Approval tripple when using Biomarkers

Clinical trial programs that used selection biomarkers saw an overall likelihood of approval (LOA) from Phase I of 25.9%, compared to 8.4% when no selection biomarkers were used. This one of the results of  the largest ever study of clinical development success rates released by the Biotechnology Innovation Organization (BIO). The study, conducted in partnership with Amplion and Biomedtracker, recorded and analyzed 9,985 clinical and regulatory phase transitions, across 1,103 companies. Using clinical trial data from the past decade, “Clinical Development Success Rates 2006-2015” compares groups of diseases, drug modalities and other attributes to generate the most comprehensive analysis, to date, of biopharmaceutical R&D success.

You can download the full report here: Clinical Development Success Rates 2006-2015

(Foto: Libertas Academica - Figure 2 from An Integrative Genomics Approach to Biomarker Discovery in Breast Cancer Published in Cancer Informatics/Flickr – CC BY 2.0)

(Foto: Libertas Academica - Figure 2 from An Integrative Genomics Approach to Biomarker Discovery in Breast Cancer Published in Cancer Informatics/Flickr – CC BY 2.0)

 
How effective is your CRO and Vendor Oversight ? CILIQUE is attending Healthtech Invest Europe 2017

Related Posts

CRO Change Order received! – Why Worry?

Blog, Blog

CRO Change Order received! – Why Worry?

CILIQUE is attending Healthtech Invest Europe 2017

Blog

CILIQUE is attending Healthtech Invest Europe 2017

How effective is your CRO and Vendor Oversight ?

Blog

How effective is your CRO and Vendor Oversight ?

Weitere News

  • CRO Change Order received! – Why Worry?CRO Change Order received! – Why Worry?
    Mai 13, 2017
  • 3 Things to consider when running a Trial in a Med Device Start-up3 Things to consider when running a Trial in a Med Device Start-up
    Oktober 12, 2016
  • Are Change Orders a Necessary Evil?Are Change Orders a Necessary Evil?
    Oktober 12, 2016
  • How the Right Governance Structure can maximize your Partnership ValueHow the Right Governance Structure can maximize your Partnership Value
    Oktober 11, 2016
  • How to Manage Operational RiskHow to Manage Operational Risk
    Oktober 10, 2016
(c) 2016 CILIQUE UG
Impressum
Diese Website benutzt Cookies. Wenn du die Website weiter nutzt, gehen wir von deinem Einverständnis aus.OK